Literature DB >> 7995797

Fluoxetine-induced memory impairment in an adolescent.

M E Bangs1, T A Petti, M D Janus.   

Abstract

This paper describes a 14-year-old male patient who complained of memory problems during treatment with fluoxetine for major depression. The patient showed impairments on all five scales of the Wechsler Memory Scale-Revised during fluoxetine treatment. Three of the scales, Verbal Memory, Visual Memory, and General Memory, showed statistically significant improvements after fluoxetine was discontinued. This case represents the first time memory deficits related to fluoxetine were quantitated with a standardized memory test. It points to cognitive side effects that need to be understood.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995797     DOI: 10.1097/00004583-199411000-00012

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  5 in total

Review 1.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Bupropion normalizes cognitive performance in patients with depression.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  MedGenMed       Date:  2007-01-31

3.  Fluoxetine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents.

Authors:  Humberto Quintana; Grant J Butterbaugh; William Purnell; Ann K Layman
Journal:  Child Psychiatry Hum Dev       Date:  2007-02

4.  Fluoxetine and the dentate gyrus: memory, recovery of function, and electrophysiology.

Authors:  Julian R Keith; Ying Wu; Jonathon R Epp; Robert J Sutherland
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

Review 5.  A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  S M Hawkridge; D J Stein
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.